new_banner

news

(5S)-1-(2-Hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxylic acid

(5S)-1-(2-hydroxyethyl)-4-methyl -5-[2-(trifluoromethyl) phenyl]-1H-pyrrole -3-carboxylic acid (CAS 1632002-11-9) is a key intermediate and impurity reference substance of oxalone (Esaxerenone), with a purity of 99%, which is suitable for pharmaceutical research and development and impurity mass spectrometry research. Our company is a conventional manufacturer, from small samples to tons of large goods can be stable supply.

Name (5S)-1-(2-Hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxylic acid
Alias ESAX-010; Esaxerenone carboxylic acid; 1H-Pyrrole-3-carboxylic acid, 1-(2-hydroxyethyl)-4-methyl-5-[2-(trifluoromethyl)phenyl]-, (5S)-
CAS No. 1632002-11-9
chemical formula C₁₅H₁₄F₃NO₃
molecular weight 313.27
InChI InChI=1S/C15H14F3NO3/c1-9-11(14(21)22)8-19(6-7-20)13(9)10-4-2-3-5-12(10)15(16,17)18/h2-5,8,20H,6-7H2,1H3,(H,21,22)
density 1.34±0.1g/cm³ (predicted)
boiling Point 456.1±45.0°C (predicted)
storage conditions 2-8°C, sealed, dark, dry storage
sensitivity sensitive to humidity, oxidant (inert atmosphere, dark recommended)
appearance solid
specific Gravity approximately 1.34 (based on density predictions)
color white to off-white (appearance of conventional pharmaceutical intermediates, specific batches slightly different)
dangerous Goods Signs Harmful if swallowed (Harmful if swallowed)
risk Terms R22 (Harmful if swallowed); specific risk terminology is based on the latest version of the MSDS
safety terminology S22/S24/S36/S45 (conventional laboratory protection and first aid measures, subject to MSDS)
customs Number HSN 38229010 (Indian code for reference; Chinese customs declaration is recommended to be classified under 3822 or 2933 according to actual composition and use)

nature

this product is a trifluoromethyl substituted phenyl pyrrole carboxylic acid solid, the molecule at the same time there are carboxyl, hydroxyl and pyrrole ring, both a certain polarity and rigid skeleton. The predicted boiling point is about 456°C, the density is about 1.34g/cm³, and the storage stability is good under normal conditions, but the strong oxidant and humid environment still need to be avoided. As a chiral (5S) configuration compound, its optical purity is one of the key indicators of quality control.

Use

this product is a key intermediate/impurity reference substance of Esaxerenone (etalone), which is mainly used for the process development of the drug synthesis route, impurity spectrum research, quality standard establishment and the use of reference substances in registration declaration. In the generic drug consistency evaluation and innovative drug CDMO project, high purity, batch-to-batch stability of the intermediate is an important guarantee to shorten the development cycle and reduce process risk.

Safety Information

according to the existing MSDS summary, this product is harmful when swallowed. Wear protective gloves, goggles and lab coat when handling, and avoid inhalation of dust or contact with skin/eyes. At present, the published ecotoxicological and acute toxicity data are limited, so it is recommended to dispose of the waste liquid in a fume hood and dispose of the waste liquid according to the local hazardous chemicals regulations. Specific risk and safety terms are subject to the latest version of the MSDS accompanying the goods.

Our advantages and production capacity: why customers choose us

1. The product is our conventional production varieties, supply certainty is strong (5S)-1-(2-hydroxyethyl)-4-methyl -5-[2-(trifluoromethyl) phenyl]-1H-pyrrole -3-carboxylic acid is our **regularly production product (conventional production products)**, not temporary outsourcing or project-type supply. Customers do not need to worry about the risk of “batch completion and supply interruption”. From research and development of small samples to large quantities above tonnage, we can deliver them stably as planned. For generic or innovative drug programs, this means that there is no need to change suppliers from preclinical to commercialization, significantly reducing technology transfer and audit costs.

2. Chiral purity and impurity control ability, directly hit the core pain points of customers the product is (5S) chiral configuration, at the same time as the use of isalenone impurity reference substance, the optical purity and chemical purity have higher requirements. Our long-term focus on pharmaceutical intermediates, APIs and pharmaceutical impurities, with a complete technical chain from chiral synthesis, preparative liquid purification to impurity spectrum attribution, to provide high inter-batch consistency, COA data integrity of the product. The customer chooses us, in essence, to choose a partner who understands impurities and registration declaration, rather than a simple “seller”.

3. One-stop support from impurity reference substance to CDMO ixalidone projects often require multiple impurity references, intermediates and subsequent process optimization support at the same time. Our company not only supplies this product, but also provides customized synthesis, unknown impurity structure analysis, reference substance standardization and other services around the etalinone series impurities. The customer is not facing an isolated SKU, but a supply chain solution that can be packaged by project and delivered by stage, with lower communication costs and faster technical response.

4. Quality system and compliance awareness we are well aware of the strict requirements of pharmaceutical intermediate customers for batch number traceability, document integrity and change notification. The company’s operations follow a standardized quality management process, COA, MSDS and other documents are available with the goods, and key batches support audit tracking. For export customers, we can cooperate to provide technical instructions and compliance documents required for customs declaration to help customers reduce customs clearance barriers.

5. Flexible business conditions, matching different stages of customers whether it is the small test demand of universities/research institutes, or the commercial procurement of pharmaceutical enterprises in kilogram and ton level, we provide ladder pricing and flexible packaging. Customers who cooperate for the first time can apply for small sample evaluation and enter bulk purchase after confirming key indicators such as purity, chiral purity and solubility, thus reducing trial and error costs.

Buyer FAQ

q1: Are you the manufacturer or trader of this product? Can you guarantee a long-term stable supply? A: We are the regular manufacturer of this product. This product is included in the company’s normal production plan, not temporary purchase and resale. From small samples to large tons of goods can be supplied, long-term cooperation agreement customers enjoy priority row property rights.

Q2: How much can chiral purity (ee value) and chemical purity be achieved? A: The conventional purity of pharmaceutical grade products can reach 99%(HPLC), and the chiral purity can be controlled and released according to customer standards. Each batch provides a complete COA, including key items such as HPLC purity, ee value, moisture, residual solvents, etc. If there is a special impurity limit requirement, the method can be confirmed before the order.

Q3: What items is this product mainly used for? Do you have any related impurity reference substance? A: This product is a key intermediate/impurity of Esaxerenone, which is widely used in the process development and impurity spectrum research of the drug. At the same time, we supply other impurity reference substances in the isalenone series, which can be packaged and inquired according to the project, thus reducing the communication cost of customers’ multi-head procurement.

Q4: What are the special requirements for storage and transportation? A: It is recommended to seal, avoid light and dry storage at 2-8°C. The short-term stability is good under normal temperature transportation conditions, but for long-term storage, please follow the label conditions. Each shipment is accompanied by storage advice and MSDS, and export orders can be accompanied by compliant shipping documents.

Q5: If we have the requirement of customized synthesis or unknown impurity structure analysis, can you accept it? A: Yes. Our core business covers customized new drug CDMO services and full-process technical support, including customized synthesis of chiral compounds, separation and preparation of unknown impurities and structural analysis. Please send the structural formula, purity target and quantity to the technical team, and we will give the preliminary plan and quotation within 2 working days.

Welcome to visit our official website to obtain the COA sample, MSDS and the latest quotation of the product: https://www.shlzpharma.com/

 


Post time: Nov-16-2026